By Eric Barnes, staff writer
    November 19, 2010

    Wednesday, December 1 | 10:30 a.m.-10:40 a.m. | SSK04-01 | Room S504AB
    Cryotherapy is a safe and effective option for lung cancer treatment, particularly in patients with unresectable tumors. In this scientific session, researchers from China will address the high recurrence rates that can affect this treatment.

    Tumor recurrence rates after cryotherapy range from 12% to 24%, and they can be even higher for larger tumors or those located near the trachea or vessels, which limit the ability of cryotherapy probes to cool the region. But the researchers from China are slashing those recurrence rates by implanting iodine-125 brachytherapy seeds concurrently with the cryotherapy procedures.

    Wei Tao Dou, MD, and colleagues from Shandong University ablated 80 lung cancer tumors (54 patients; mean age, 57.6 years) with cryotherapy and iodine-125 seeds on the periphery of the tumor during the two-year course of the study. The tumors ranged in size from 2 to 8 cm (mean, 4.6 cm). Single or multiple 17-mm cryoprobes were used for ablation of the central zone, and seeds were implanted along the edge of the ablation region, the authors noted.

    At follow-up of three to 19 months, the researchers examined the results based on tumor size, changes in tumor markers, and disease recurrence. They found tumor markers reduced, tumor sizes reduced, and targeted tumor recurrence at one, three, and six months of 0% (0/80), 4% (3/80), and 6% (5/80), respectively -- much lower than previous reports without the use of iodine-125. Four cases of symptomatic pneumothorax were detected postprocedurally at CT.

    Cryotherapy plus brachytherapy is safe and offers lower recurrence rates than cryotherapy alone, the group concluded.

    Last Updated np 11/18/2010 2:37:42 PM

    || About || Advertising || || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2014 || Education || Equipment Classifieds || Europe || Facebook || Forums || Home || Links || Marketplace || Middle East || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2013 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2021 All Rights Reserved.